Head & neck · 2026
Intensive Swallowing Rehabilitation for Head and Neck Cancer Survivors With Chronic Dysphagia: Outcomes From a Prospective Multicentre Cohort Study With 6-Month Follow-Up.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oldenbeuving J I, van der Molen L, Groothuis J T, Kalf J G
Аннотация
BACKGROUND: Chronic dysphagia persists in some head and neck cancer (HNC) survivors despite preventive exercises, negatively impacting quality of life. Evidence for effective rehabilitation strategies remains limited.
METHODS: This prospective cohort study included 34 HNC survivors (≥ 1 year post-treatment) who completed a 3-week intensive swallowing rehabilitation (ISR) program (15 sessions, 60 min/day). Outcomes were measured at baseline (T0), post-treatment (T1), and 6-month follow-up (T2) using patient-rated (VAS, MDADI, PSS-HN), clinician-rated (food level, AUS-TOM), and objective swallowing outcomes (MSS, MSV, TOMASS).
RESULTS: ISR was feasible and safe (92% completion, no adverse events). Patient-rated and most clinician-rated outcomes improved significantly post-ISR and remained stable at 6 months (VAS: p < 0.001; PSS-HN: p < 0.001; food level: p = 0.002). MDADI and AUS-TOM for solids further improved at follow-up. Objective swallowing tests showed no clinically relevant change.
CONCLUSION: ISR effectively improves normalcy of diet and quality of life in HNC survivors with chronic dysphagia, with benefits sustained at 6 months.
METHODS: This prospective cohort study included 34 HNC survivors (≥ 1 year post-treatment) who completed a 3-week intensive swallowing rehabilitation (ISR) program (15 sessions, 60 min/day). Outcomes were measured at baseline (T0), post-treatment (T1), and 6-month follow-up (T2) using patient-rated (VAS, MDADI, PSS-HN), clinician-rated (food level, AUS-TOM), and objective swallowing outcomes (MSS, MSV, TOMASS).
RESULTS: ISR was feasible and safe (92% completion, no adverse events). Patient-rated and most clinician-rated outcomes improved significantly post-ISR and remained stable at 6 months (VAS: p < 0.001; PSS-HN: p < 0.001; food level: p = 0.002). MDADI and AUS-TOM for solids further improved at follow-up. Objective swallowing tests showed no clinically relevant change.
CONCLUSION: ISR effectively improves normalcy of diet and quality of life in HNC survivors with chronic dysphagia, with benefits sustained at 6 months.